Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

Conditions:   Platelet Aggregation;   Type 2 Diabetes;   Aspirin;   Diabetes Mellitus, Type 2;   Platelet Aggregation Inhibitors Interventions:   Drug: Aspirin 81Mg Ec Tab twice daily for 7 days;   Drug: Aspirin 40Mg Chew Tab twice daily for 7 days;   Drug: Aspirin 162 mg EC Tab once daily for 7 days Sponsors:   Montreal Heart Institute;   Institut de Recherches Cliniques de Montreal Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials